TET2 loss of function mutations are frequently found in patients suffering from myeloid malignancies such as acute myeloid leukemia, myeloproliferative neoplasms, or myelodysplastic syndromes [15,20,104] (Table 1). Here, TET2 is linked to acute myeloid leukemia.